Literature DB >> 21057315

Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury.

Martin Westphal1, Sebastian Rehberg, Marc O Maybauer, Dirk M Maybauer, Perenlei Enkhbaatar, Beena B Westphal-Varghese, Frank C Schmalstieg, Naoki Morita, Robert A Cox, Lillian D Traber, Hal Hawkins, Elbert Whorton, Daniel L Traber.   

Abstract

OBJECTIVE: To elucidate the effects of low-dose arginine vasopressin on cardiopulmonary functions and nitrosative stress using an established model of acute lung injury.
DESIGN: Prospective, randomized, controlled laboratory experiment.
SETTING: Investigational intensive care unit.
SUBJECTS: Eighteen chronically instrumented sheep.
INTERVENTIONS: Sheep were randomly assigned to a sham group without injury or treatment, an injury group without treatment (40% total body surface area third-degree burn and 48 breaths of cold cotton smoke), or an injured group treated with arginine vasopressin (0.02 IU·min⁻¹) from 1 hr after injury until the end of the 24-hr study period (each n = 6). All sheep were mechanically ventilated and fluid resuscitated using an established protocol.
MEASUREMENTS AND MAIN RESULTS: There were no differences among groups at baseline. The injury was characterized by a severe deterioration of cardiopulmonary function (left ventricular stroke work indexes and Pao2/Fio2 ratio; p < .01 each vs. sham). Compared with controls, arginine vasopressin infusion improved myocardial function, as suggested by higher stroke volume indexes and left ventricular stroke work indexes (18-24 hrs and 6-24 hrs, respectively; p < .05 each). In addition to an improved gas exchange (higher Pao2/Fio2 ratios from 6 to 24 hrs, p < .01 each), pulmonary edema (bloodless wet-to-dry-weight ratio; p = .018), bronchial obstruction (p = .01), and pulmonary shunt fraction (12-24 hrs; p ≤ .001 each) were attenuated in arginine vasopressin-treated animals compared with controls. These changes occurred along with reduced nitrosative stress, as indicated by lower plasma levels of nitrate/nitrite (12-24 hrs, p < .01 each), as well as lower myocardial and pulmonary tissue concentrations of 3-nitrotyrosine (p = .041 and p = .042 vs. controls, respectively). At 24 hrs, pulmonary 3-nitrotyrosine concentrations were negatively correlated with Pao2/Fio2 ratio (r = -.882; p < .001) and myocardial 3-nitrotyrosine content with stroke volume indexes (r = -.701; p = .004).
CONCLUSIONS: Low-dose arginine vasopressin reduced nitrosative stress and improved cardiopulmonary functions in sheep with acute lung injury secondary to combined burn and smoke inhalation injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21057315     DOI: 10.1097/CCM.0b013e3181feb802

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.

Authors:  Muhuo Ji; Renqi Li; Guo-min Li; Yunxia Fan; Lin Dong; Jianjun Yang; Yong G Peng; Jing Wu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Protective effects of hydrogen sulfide inhalation on oxidative stress in rats with cotton smoke inhalation-induced lung injury.

Authors:  Zhi-Hai Han; Y I Jiang; Yun-You Duan; Xiao-Yang Wang; Yan Huang; Ting-Zheng Fang
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

3.  Experimental sepsis in pigs--effects of vasopressin on renal, hepatic, and intestinal dysfunction.

Authors:  Mu-Huo Ji; Jian-Jun Yang; Jing Wu; Ren-Qi Li; Guo-Min Li; Yun-Xia Fan; Wei-Yan Li
Journal:  Ups J Med Sci       Date:  2012-01-27       Impact factor: 2.384

Review 4.  Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care.

Authors:  Saul Chemonges; Kiran Shekar; John-Paul Tung; Kimble R Dunster; Sara Diab; David Platts; Ryan P Watts; Shaun D Gregory; Samuel Foley; Gabriela Simonova; Charles McDonald; Rylan Hayes; Judith Bellpart; Daniel Timms; Michelle Chew; Yoke L Fung; Michael Toon; Marc O Maybauer; John F Fraser
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

5.  Perioperative "remote" acute lung injury: recent update.

Authors:  Zhaosheng Jin; Ka Chun Suen; Daqing Ma
Journal:  J Biomed Res       Date:  2017-01-19

6.  Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.

Authors:  Evandro M Neto-Neves; Ozelia Sousa-Santos; Karina C Ferraz; Elen Rizzi; Carla S Ceron; Minna M D Romano; Luis G Gali; Benedito C Maciel; Richard Schulz; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  J Cell Mol Med       Date:  2013-11-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.